Skip to main content
AmigoFish

The Role of Biosimilars in Managing Inflammatory Disease

From CEimpact Podcast · · 42 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions.

HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls

GUEST Reemal Zaheer, PharmD, CSP Pharmacist Johns Hopkins Medicine

GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more!

The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/)

PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/).

CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

- If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####).

- To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/)

CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of biosimilars in the treatment of inflammatory conditions. 2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies.

Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose.

0.075 CEU/0.75 Hr UAN: 0107-0000-26-045-H01-P Initial release date: 2/2/2026 Expiration date: 2/2/2029 Additional CPE details can be found here (https://www.ceimpact.com/courses/the-role-of-biosimilars-in-managing-inflammatory-disease/).

Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)

Back to CEimpact Podcast · Report a problem